IP Library Granted Patent US 12,616,514
Granted Patent B2
US 12,616,514 · App. 17/980,081 · Granted May 5, 2026

Systems and methods for treating chronic sinusitis

Inventor: David Townley (County Clare, IE)
Assignee: Neurent Medical Limited
A61B18/1485A61B18/02A61B2018/0022A61B2018/00327A61B2018/00434A61B2018/00577A61B2018/00642A61B2018/1467
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,616,514
App. No.
17/980,081
Granted
May 5, 2026
Kind
B2
Abstract

The invention generally relates to systems and methods for targeting of specific tissue(s) of interest within a sino-nasal region of a patient, specifically sinus regions (i.e., ostia and sinus cavities), for the treatment of chronic sinusitis conditions.

Claims (16)

1 . A method for treating chronic sinusitis, the method comprising:

advancing an end effector, disposed at a distal end of a shaft of a treatment device, within a sino-nasal cavity of a patient;

positioning and deploying the end effector relative to one or more target sites associated with at least one of an ostium and cavity of a paranasal sinus, wherein the end effector comprises a first segment comprising a first set of flexible support elements and a second segment comprising a second set of flexible support elements, wherein the first and second segments each have an open-ended circumferential shape when deployed and generally oppose one another in that the first and second segments extend in opposing directions along a longitudinal axis of the shaft; and

delivering energy, from a plurality of energy delivery elements provided on the first and second segments, at the one more target to disrupt neural signals to mucus producing and/or mucosal engorgement elements associated with the paranasal sinus.

2 . The method of claim 1 , wherein the paranasal sinus is selected from the group consisting of a frontal sinus, a sphenoidal sinus, a maxillary sinus, and an ethmoidal sinus.

3 . The method of claim 1 , wherein delivering energy results in ablation of targeted tissue at multiple locations to thereby disrupt the multiple neural signals to the mucus producing and/or mucosal engorgement elements.

4 . The method of claim 3 , wherein the ablation is thermal ablation.

5 . The method of claim 3 , wherein the ablation is caused by delivery of radio-frequency energy.

6 . The method of claim 3 , further comprising receiving feedback, prior to, during, and/or after the ablation.

7 . The method of claim 1 , wherein each of the flexible support elements includes one or more energy delivery elements provided thereon.

8 . The method of claim 7 , wherein each of the flexible support elements comprises a plurality of energy delivery elements provided thereon.

9 . The method of claim 7 , wherein the end effector is transformable from a retracted configuration to an expanded configuration.

10 . The method of claim 9 , wherein the one or more flexible support elements comprises shape memory material.

11 . The method of claim 9 , wherein, when in the expanded configuration, the end effector positions the one or more energy delivery elements relative to parasympathetic nerves inverting the paranasal sinus.

12 . The method of claim 11 , wherein the disrupting of neural signals reduces hyperactive mucosal secretions and soft tissue engorgement of the paranasal sinus.

13 . The method of claim 1 , wherein the end effector comprises at least one inflatable member.

Assignments (2)
SECURITY INTEREST Recorded Oct 18, 2024
From: NEURENT MEDICAL LIMITED
To: CLARET EUROPEAN SPECIALTY LENDING COMPANY III, S.A R.L.
Reel/Frame 068942/0887 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 28, 2022
From: TOWNLEY, DAVID
To: NEURENT MEDICAL LIMITED
Reel/Frame 061889/0877 →
Continuity (2)
Provisional Application 63275701 · Nov 4, 2021
Related Publication 20230133359A1 · May 4, 2023
References Cited (60)
US 874178A · De Forest · 1907 [cited by applicant]
US 3117571A · Fry et al. · 1964 [cited by applicant]
US 3538919A · Meyer · 1970 [cited by applicant]
US 3941121A · Olinger et al. · 1976 [cited by applicant]
US 4271848A · Turner et al. · 1981 [cited by applicant]
US 4411266A · Cosman · 1983 [cited by applicant]
US 5562720A · Stern et al. · 1996 [cited by applicant]
US 5575788A · Baker et al. · 1996 [cited by applicant]
US 5746224A · Edwards · 1998 [cited by applicant]
US 5766605A · Sanders et al. · 1998 [cited by applicant]
US 5800429A · Edwards · 1998 [cited by applicant]
US 6033397A · Laufer et al. · 2000 [cited by applicant]
US 6273886B1 · Edwards et al. · 2001 [cited by applicant]
US 6517534B1 · McGovern et al. · 2003 [cited by applicant]
US 6517535B2 · Edwards · 2003 [cited by applicant]
US 6669689B2 · Lehmann et al. · 2003 [cited by applicant]
US 6685648B2 · Flaherty et al. · 2004 [cited by applicant]
US 7608275B2 · Deem et al. · 2009 [cited by applicant]
US 7655243B2 · Deem et al. · 2010 [cited by applicant]
US 8105817B2 · Deem et al. · 2012 [cited by applicant]
US 8133497B2 · Deem et al. · 2012 [cited by applicant]
US 8338164B2 · Deem et al. · 2012 [cited by applicant]
US 8636684B2 · Deem et al. · 2014 [cited by applicant]
US 8936594B2 · Wolf et al. · 2015 [cited by applicant]
US 8939970B2 · Stone et al. · 2015 [cited by applicant]
US 8961391B2 · Deem et al. · 2015 [cited by applicant]
US 9072597B2 · Wolf et al. · 2015 [cited by applicant]
US 9415194B2 · Wolf et al. · 2016 [cited by applicant]
US 9498283B2 · Deem et al. · 2016 [cited by applicant]
US 9700707B2 · Deem et al. · 2017 [cited by applicant]
US 10022529B2 · Deem et al. · 2018 [cited by applicant]
US 10052465B2 · Deem et al. · 2018 [cited by applicant]
US 10307200B2 · Saadat · 2019 [cited by applicant]
US 10610675B2 · Deem et al. · 2020 [cited by applicant]
US 10729897B2 · Deem et al. · 2020 [cited by applicant]
US 10894011B2 · Deem et al. · 2021 [cited by applicant]
US 11033318B2 · Wolf et al. · 2021 [cited by applicant]
US 11241271B2 · Wolf et al. · 2022 [cited by applicant]
US 11679077B2 · Deem et al. · 2023 [cited by applicant]
US 11766286B2 · Wolf et al. · 2023 [cited by applicant]
US 20050171574A1 · Rubinsky et al. · 2005 [cited by applicant]
US 20050240147A1 · Makower et al. · 2005 [cited by applicant]
US 20070219600A1 · Gertner et al. · 2007 [cited by applicant]
US 20070287994A1 · Patel · 2007 [cited by applicant]
US 20080021369A1 · Deem et al. · 2008 [cited by applicant]
US 20140114233A1 · Deem et al. · 2014 [cited by applicant]
US 20140243793A1 · Morriss et al. · 2014 [cited by applicant]
US 20160331459A1 · Townley et al. · 2016 [cited by applicant]
US 20180133460A1 · Townley et al. · 2018 [cited by applicant]
US 20200179682A1 · Townley et al. · 2020 [cited by applicant]
US 20200179683A1 · Townley · 2020 [cited by examiner]
US 20200405383A1 · Townley · 2020 [cited by applicant]
WO 2010077980A1 · 2010 [cited by applicant]
WO 2016183337A2 · 2016 [cited by applicant]
Arora, 1980, Cryodestruction of Vidian Nerve Branches, Indian Journal of Otolaryngology, 32(3):80-82. [cited by applicant]
Chen, 2005, Radiofrequency treatment of nasal posterior-under nerve ethmoidal nerve and infraturbinal for perennial allergic rhinitis under nasal endoscope, China Journal of Endoscopy, 11(3):239-243. [cited by applicant]
Fang, 2005, Nasal endoscopy combined with multiple radiofrequency for perennial allergic rhinitis, J. First Mil. Medic Univ., 25(7):876-877. [cited by applicant]
Kong, 2005, Low-temperature plasma ablation of inferior turbinate for the treatment of perennial allergic rhinitis, 19:5 J Clin Otorhinolaryngol (China), 19:5:214. [cited by applicant]
Lane, 2004, Nasal anatomy and physiology, Facial Plast Surg Clin North Am., 12(4):387-395. [cited by applicant]
Liang, 1999, Radiofrequency treatment of ethmoidal nerve with allergic rhinitis under nasal endoscopy, J. Clin Otorhinolaryngol, 13(8):341-342. [cited by applicant]